ZYNE Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry (AACAP) 2020 Annual Meeting

Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry (AACAP) 2020 Annual Meeting
EN
08/10/2020

Underlying

ZYNEZynerba Pharmaceuticals

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Zynerba Pharmaceuticals

 PRESS RELEASE
Free
ZYNE Zynerba Pharmac...

Important Information for Zynerba Pharmaceuticals Stockholders to Tend...

Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions DEVON, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today reminds all stockholders, including individual stockholders, to promptly tender their shares into the tender offer (the “Offer”) by Harmony Biosciences Holdings, Inc. (“Harmony”) and its wholly owned subsidiary, Xylophone Acquisition Corp. (“Purchaser”), to purc...

October 4, 2023 1 EN
 PRESS RELEASE
Free
ZYNE Zynerba Pharmac...

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before ...

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023 DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today released the following letter to stockholders concerning the pending tender offer by Harmony Biosciences Holdings, Inc. (“Harmony”). Fellow Zynerba Pharmaceuticals Stockholders, We urge you to promptly tender your shares in response to the pending tender...

September 29, 2023 1 EN
 PRESS RELEASE
Free
ZYNE Zynerba Pharmac...

Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeti...

Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting Annual Meeting to Reconvene on August 25, 2023 at 9:00 a.m. EDT DEVON, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) (the “Company”), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that the new date for the adjourned 2023 Annual Meeting of Stockholders (“Annual Meeting”) is August 25, 2023 at 9:00 a.m. EDT in order to provide stockholders additional time to consider and vote on Proposal...

August 8, 2023 1 EN
 PRESS RELEASE
Free
ZYNE Zynerba Pharmac...

Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeti...

Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting Annual Meeting to Reconvene on August 11, 2023 at 9:00 a.m. EDT DEVON, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) (the “Company”), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that the new date for the adjourned 2023 Annual Meeting of Stockholders (“Annual Meeting”) is August 11, 2023 at 9:00 a.m. EDT in order to provide stockholders additional time to consider and vote on Proposal...

July 25, 2023 1 EN
 PRESS RELEASE
Free
ZYNE Zynerba Pharmac...

Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meetin...

Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting Annual Meeting Reconvened and Adjourned Without Conducting Business Meeting to Reconvene on July 27, 2023 at 9:00 am EDT DEVON, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) (the “Company”), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that the adjourned 2023 Annual Meeting of Stockholders (“Annual Meeting”) was reconvened and then adjourned, without conducting any business, in order t...

June 28, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch